Pre-Exposure Prophylaxis (PrEP) is currently a medication used to prevent HIV infection before exposure to the virus, aiming to provide individuals at risk with enhanced means of self-protection. For those with questions about PrEP, today InTouchMedCare compiles essential information covering what to know, dosing regimens, discontinuation procedures, and effectiveness in prevention to address any uncertainties.
For those who are curious about what symptoms may occur if they have already contracted the infection, You can read article ‘What happens when you get HIV?’ to learn more about. However, it's important to note upfront that prevention is only for HIV and cannot prevent other sexually transmitted infections. The most crucial aspect is discipline: taking medication consistently on time and avoiding missed doses.
Pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV infection from sexual intercourse, with an efficacy of up to 99% when taken correctly. It also demonstrates efficacy in preventing infection among people who inject drugs, estimated at around 74%.
You can check the price of PrEP medication by clicking here.
Before starting PrEP medication, it is essential to consult with a healthcare provider for a medical history assessment, including any pre-existing conditions. Additionally, HIV blood testing is necessary to detect the HIV virus before starting the medication. Some individuals may also need kidney function tests before starting the medication. For those at risk of pregnancy, pregnancy testing is recommended. Screening for other sexually transmitted infections, such as hepatitis B and C viruses, syphilis, gonorrhea, and chlamydia, is also advised for comprehensive care.
PrEP can be taken in two different ways: daily and on-demand. Daily PrEP is generally recommended over on-demand PrEP because it is easier to adhere to.
PrEP cannot be purchased over the counter at general pharmacies; it must be prescribed by a licensed healthcare provider. Before taking the medication, individuals must undergo HIV blood testing to allow the physician to diagnose and provide guidance on medication usage, as it may have side effects for some patients. Services can be accessed at private clinics near one's residence and hospitals.
You can check the price of PrEP medication by clicking here.
You can stop taking the medication if there is no longer a tendency to engage in risky behavior or if there are significant side effects and you no longer wish to continue. It is recommended to continue taking the medication for up to 7 days after the last risky exposure and then stop. You can return for consultation to resume medication if you begin engaging in risky behavior again. Before discontinuing each time, blood tests should be conducted to ensure there is no infection.
Doctors will schedule follow-up appointments during PrEP usage every 1-3 months to conduct HIV blood tests to ensure there is no infection. They may also monitor kidney function every 3-6 months in some cases, as well as track any side effects resulting from medication usage.
PrEP can be used alongside contraceptive methods, including oral contraceptives, injectable contraceptives, implant contraceptives, and barrier contraceptives, without any risks.
Taking PrEP medication only prevents HIV virus infection but does not protect against other sexually transmitted diseases or prevent pregnancy.
PrEP medication must be prescribed by a licensed healthcare provider. Therefore, you can obtain the medication by contacting hospitals and clinics nearby that offer this service.
Although PrEP medication significantly reduces the risk of HIV infection, there is still a possibility of risk. It is advisable to use medication in conjunction with condoms to prevent the chance of contracting other sexually transmitted diseases. Additionally, it is crucial to adhere to the PrEP medication schedule consistently for the safety of one's health.
Reference
Centers for Disease C, Prevention.PREEXPOSURE PROPHYLAXIS FOR THE PREVENTION OF HIV INFECTION IN THE UNITED STATES – 2021 UPDATE,Clinical practice guideline
Centers for Disease C, Prevention. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morbidity and mortality weekly report. 2012;61(31):586-9.
กองโรคเอดส์และโรคติดต่อทางเพศสัมพันธ์ กรมควบคุมโรค กระทรวงสาธารณสุข.แนวทางการตรวจวินิจฉัย รักษา และป้องกัน การติดเชื้อ HIV ประเทศไทย ปี 2564/2565
กองโรคเอดส์และโรคติดต่อทางเพศสัมพันธ์ กรมควบคุมโรค กระทรวงสาธารณสุข.แนวทางการจัดการบริการยาป้องกันก่อนการสัมผัสเชื้อเอชไอวี ประเทศไทย ปี 2564
กองโรคเอดส์และโรคติดต่อทางเพศสัมพันธ์ กรมควบคุมโรค กระทรวงสาธารณสุข
Compiled by Nattawadee Sriborisut, MD
Last Update : 19/03/2024